Health Catalyst, Inc Common Stock (HCAT) is a publicly traded Healthcare sector company. As of July 21, 2026, HCAT trades at $2.17 with a market cap of $166.26M and a P/E ratio of -0.58. HCAT moved +0.00% today. Year to date, HCAT is -9.24%; over the trailing twelve months it is -40.82%. Its 52-week range spans $0.96 to $9.24. Analyst consensus is neutral with an average price target of $2.08. Rallies surfaces HCAT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for HCAT shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $2.17 |
| Market Cap | $166.26M |
| P/E Ratio | -0.58 |
| EPS | $-3.74 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.24 |
| 52-Week Low | $0.96 |
| Volume | 110.82K |
| Avg Volume | 0 |
| Revenue (TTM) | $302.48M |
| Net Income | $-265.26M |
| Gross Margin | 0.00% |
8 analysts cover HCAT: 0 strong buy, 2 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $2.08.